Clinical trial
Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures
NCT00275925 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00275925 |
|---|---|
| Title | Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures |
| Official title | A 24-Week Prospective, Open-Label, Multicenter Study to Evaluate the Effect on Seizure Frequency, Safety and Tolerability of Oxcarbazepine Monotherapy in Adult Patients With Partial Seizures |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epilepsy, Partial Seizures |
| Intervention type | Drug |
| Interventions | Oxcarbazepine |
| Enrollment | 80 |
| Start date | Dec 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | Jan 12, 2006 |
| Last update posted | Nov 30, 2007 |
| Countries | Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: